Anders Sönnerborg

Prof. Anders Sönnerborg

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2013 in Retrovirology
Verified
Journal Article
Open access
PDF file
AAAna Abecasis
Ana Abecasis
AWannemarie M.J. wensing
annemarie M.J. wensing
Dimitrios ParaskevisDimitrios Paraskevis
Dimitrios Paraskevis
JVJurgen Vercauteren
Jurgen Vercauteren
KTKristof Theys
Kristof Theys
AVAnne-Mieke Vandamme
Anne-Mieke Vandamme
Understanding HIV-1 subtype distribution and epidemiology can assist preventive measures and clinical decisions. Sequence variation may affect antiviral drug resistance development, disease progression, evolutionary rates and transmission routes.

29 June 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
TSTakuya Sekine
Takuya Sekine
APAndré Perez-Potti
André Perez-Potti
OROlga Rivera-Ballesteros
Olga Rivera-Ballesteros
KSKristoffer Strålin
Kristoffer Strålin
JGJean-Baptiste Gorin
Jean-Baptiste Gorin
MBMarcus Buggert
Marcus Buggert
SARS-CoV-2-specific memory T cells will likely prove critical for long-term immune protection against COVID-19. We systematically mapped the functional and phenotypic landscape of SARS-CoV-2-specific T cell responses in a large cohort of unexposed individuals as well as exposed family members and individuals with acute or convalescent COVID-19. Acute phase SARS-CoV-2-specific T cells displayed a highly activated cytotoxic phenotype that correlated with various clinical markers of disease severity, whereas convalescent phase SARS-CoV-2-specific T cells were polyfunctional and displayed a stem-like memory phenotype. Importantly, SARS-CoV-2-specific T cells were detectable in antibody-seronegative family members and individuals with a history of asymptomatic or mild COVID-19. Our collective dataset shows that SARS-CoV-2 elicits robust memory T cell responses akin to those observed in the context of successful vaccines, suggesting that natural exposure or infection may prevent recurrent episodes of severe COVID-19 also in seronegative individuals.

12 March 2009 in European Journal of Immunology
Verified
Journal Article
Open access
PDF file
MMMarkus Moll
Markus Moll
CKCarlotta Kuylenstierna
Carlotta Kuylenstierna
VGVeronica D. Gonzalez
Veronica D. Gonzalez
SASofia K. Andersson
Sofia K. Andersson
LBLidija Bosnjak
Lidija Bosnjak
JSJohan Sandberg
Johan Sandberg
Invariant CD1d‐restricted NKT cells play important roles in regulating both innate and adaptive immunity. They are targeted by HIV‐1 infection and severely reduced in number or even lost in many infected subjects. Here, we have investigated the characteristics of NKT cells retained by some patients despite chronic HIV‐1 infection. NKT cells preserved under these circumstances displayed an impaired ability to proliferate and produce IFN‐γ in response to CD1d‐restricted lipid antigen as compared with cells from uninfected control subjects. HIV‐1 infection was associated with an elevated expression of the inhibitory programmed death‐1 (PD‐1) receptor (CD279) on the CD4− subset of NKT cells. However, blocking experiments indicated that the functional defects in NKT cells were largely PD‐1‐independent. Furthermore, the elevated PD‐1 expression and the functional defects were not restored by anti‐retroviral treatment, and the NKT cell numbers in blood did not recover significantly in response to treatment. The functional phenotype of NKT cells in these patients suggests an irreversible immune exhaustion due to chronic activation in vivo. The data demonstrate a severe functional impairment in the remaining NKT‐cell compartment in HIV‐1‐infected patients, which limits the prospects to mobilize these cells in immunotherapy approaches in patients.

18 December 2025 in Science
Verified
Journal Article
Closed access
MÁMaría Bueno Álvez
María Bueno Álvez
SBSofia Bergström
Sofia Bergström
JKJosefin Kenrick
Josefin Kenrick
EJEmil Johansson
Emil Johansson
MAMikael Aberg
Mikael Aberg
MUMathias Uhlen
Mathias Uhlen
The human blood proteome provides a holistic readout of health states through the assessment of thousands of circulating proteins. In this study, we present a pan-disease resource to enable the study of diverse disease phenotypes within a harmonized proteomics dataset. By profiling protein concentrations across 59 diseases and healthy cohorts, we identified proteins associated with age, sex, and body mass index, as well as disease-specific signatures. This study highlights shared and distinct protein patterns across conditions, demonstrating the power of a unified proteomics approach to uncover biological insights. The dataset, covering 8262 individuals and up to 5416 proteins, serves as an online resource for exploring disease-specific protein profiles and advancing precision medicine research.

1 August 2013 in Infection, Genetics and Evolution
Verified
Journal Article
Closed access
EAEmmi Andersson
Emmi Andersson
WSWei Shao
Wei Shao
IBIrene Bontell
Irene Bontell
FCFatim Cham
Fatim Cham
DCDo Duy Cuong
Do Duy Cuong
MJMichael R. Jordan
Michael R. Jordan

21 July 2014 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
DFDineke Frentz
Dineke Frentz
DVDavid Van De Vijver
David Van De Vijver
AAAna Abecasis
Ana Abecasis
JAJan Albert
Jan Albert
OHOsamah Hamouda
Osamah Hamouda
CBCharles AB Boucher
Charles AB Boucher
One out of ten newly diagnosed patients in Europe was infected with a virus carrying a drug resistant mutation. We analysed the patterns over time for transmitted drug resistance mutations (TDRM) using data from the European Spread program.